Terms: = Prostate cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Staging
46 results:
1. Comparative Prospective and Longitudinal Analysis on the Platelet-to-Lymphocyte, Neutrophil-to-Lymphocyte, and Albumin-to-Globulin Ratio in Patients with Non-Metastatic and Metastatic prostate cancer.
Salciccia S; Frisenda M; Bevilacqua G; Viscuso P; Casale P; De Berardinis E; Di Pierro GB; Cattarino S; Giorgino G; Rosati D; Del Giudice F; Carbone A; Pastore A; Chung BI; Eisenberg ML; Autorino R; Crivellaro S; Forte F; Sciarra A; Mariotti G; Gentilucci A
Curr Oncol; 2022 Dec; 29(12):9474-9500. PubMed ID: 36547159
[TBL] [Abstract] [Full Text] [Related]
2. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
Zlobec I; Lugli A
World J Gastroenterol; 2009 Dec; 15(47):5898-906. PubMed ID: 20014453
[TBL] [Abstract] [Full Text] [Related]
3. Prolonged survival using anti-cd20 combined chemotherapy in primary prostatic intravascular large B-cell lymphoma.
Csomor J; Kaszás I; Kollár B; Pajor L; Egyházi Z; Fekete S; Egyed M; Timár B
Pathol Oncol Res; 2008 Sep; 14(3):281-4. PubMed ID: 18493873
[TBL] [Abstract] [Full Text] [Related]
4. Radioimmunoscintigraphy for postprostatectomy radiotherapy: analysis of toxicity and biochemical control.
Jani AB; Blend MJ; Hamilton R; Brendler C; Pelizzari C; Krauz L; Sapra B; Vijayakumar S; Awan A; Weichselbaum RR
J Nucl Med; 2004 Aug; 45(8):1315-22. PubMed ID: 15299055
[TBL] [Abstract] [Full Text] [Related]
5. KAI1, a putative marker for metastatic potential in human breast cancer.
Yang X; Welch DR; Phillips KK; Weissman BE; Wei LL
Cancer Lett; 1997 Nov; 119(2):149-55. PubMed ID: 9570365
[TBL] [Abstract] [Full Text] [Related]
6. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
Hirao Y; Ozono S; Kagebayashi Y; Yoshi M; Tani Y; Uemura H; Momose H; Okajima E
Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
[TBL] [Abstract] [Full Text] [Related]
7. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer.
Narayan P; Gajendran V; Taylor SP; Tewari A; Presti JC; Leidich R; Lo R; Palmer K; Shinohara K; Spaulding JT
Urology; 1995 Aug; 46(2):205-12. PubMed ID: 7542823
[TBL] [Abstract] [Full Text] [Related]
8. Indications for laparoscopic pelvic lymph node dissection in the staging of prostate cancer.
Patel MI; Katelaris PM
Aust N Z J Surg; 1995 Apr; 65(4):233-6. PubMed ID: 7536410
[TBL] [Abstract] [Full Text] [Related]
9. Characterization of mouse monoclonal antibody B1.4 reactive with human invasive bladder cancer and some other malignant tumors but not with normal urinary epithelium.
Saiki S; Kinouchi T; Kuroda M; Uenaka A; Nakayama E; Kotake T
Jpn J Cancer Res; 1994 Jul; 85(7):756-61. PubMed ID: 8071117
[TBL] [Abstract] [Full Text] [Related]
10. Results of external beam radiotherapy in 448 patients with clinically localized adenocarcinoma of the prostate.
Mameghan H; Fisher R; Mameghan J; Brook S
Aust N Z J Surg; 1994 Jun; 64(6):389-94. PubMed ID: 8010899
[TBL] [Abstract] [Full Text] [Related]
11. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.
Bluestein DL; Bostwick DG; Bergstralh EJ; Oesterling JE
J Urol; 1994 May; 151(5):1315-20. PubMed ID: 7512662
[TBL] [Abstract] [Full Text] [Related]
12. [Laparoscopic pelvic lymphadenectomy for localized prostate cancer].
Igarashi T; Yuki T; Tobe T; Mikami K; Murakami S; Matsuzaki O; Shimazaki J
Nihon Hinyokika Gakkai Zasshi; 1994 Apr; 85(4):579-83. PubMed ID: 8189656
[TBL] [Abstract] [Full Text] [Related]
13. [The local relapse of prostatic cancer and initial local treatment].
Maezawa H; Komatsu H; Furuya T; Tago K; Ueno A
Nihon Hinyokika Gakkai Zasshi; 1993 Sep; 84(9):1685-9. PubMed ID: 8411824
[TBL] [Abstract] [Full Text] [Related]
14. Clinical Stage B0 or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration.
Stormont TJ; Farrow GM; Myers RP; Blute ML; Zincke H; Wilson TM; Oesterling JE
Urology; 1993 Jan; 41(1):3-8. PubMed ID: 7678359
[TBL] [Abstract] [Full Text] [Related]
15. Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer.
Petros JA; Catalona WJ
J Urol; 1992 Jun; 147(6):1574-5. PubMed ID: 1593688
[TBL] [Abstract] [Full Text] [Related]
16. [Laparoscopic pelvic lymphadenectomy in patients with localized prostate cancer].
Matsuda T; Arai Y; Terachi T; Oishi K; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1992 Apr; 38(4):419-24. PubMed ID: 1388321
[TBL] [Abstract] [Full Text] [Related]
17. Are three substages of clinical B prostate carcinoma useful in predicting disease-free survival?
Glick AJ; Philput CB; el Mahdi A; Ladaga L; Schellhammer PF
Urology; 1990 Dec; 36(6):483-7. PubMed ID: 2247912
[TBL] [Abstract] [Full Text] [Related]
18. Adenocarcinoma of the prostate treated with external-beam radiation therapy: 5-year minimum follow-up.
Amdur RJ; Parsons JT; Fitzgerald LT; Million RR
Radiother Oncol; 1990 Jul; 18(3):235-46. PubMed ID: 2120741
[TBL] [Abstract] [Full Text] [Related]
19. prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients.
Stamey TA; Kabalin JN
J Urol; 1989 May; 141(5):1070-5. PubMed ID: 2468794
[TBL] [Abstract] [Full Text] [Related]
20. Intraprostatic tumor location and pelvic lymph node metastatic pattern in early prostate cancer.
Nseyo UO; Pontes JE
Urology; 1989 Mar; 33(3):171-4. PubMed ID: 2919475
[TBL] [Abstract] [Full Text] [Related]
[Next]
